Skip to content

Prospective cohort study on disease progression, phenotype, genotype and related biological factors in patients receiving specific immunotherapy

Prospective cohort study on disease progression, phenotype, genotype and related biological factors in patients receiving specific immunotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065686
Enrollment
Unknown
Registered
2022-11-11
Start date
2022-11-21
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic disease

Interventions

Sponsors

Chongqing Northern Kuanren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Male or female, and sign the informed consent form before conducting any research operation; 2. Aged over 18; 3. Patients diagnosed with allergic rhinitis or allergic asthma; 4. Indications for specific immunotherapy in accordance with the 2012 Chinese clinical practice expert consensus on specific immunotherapy.

Exclusion criteria

Exclusion criteria: 1. The subject is in the acute exacerbation or active phase of any disease and other unstable clinical conditions; Including but not limited to myocardial infarction, stroke, and shock in recent 3 months; In the last 4 weeks, the function of gravity center was unstable, angina pectoris, massive hemoptysis, and seizures; Pneumothorax, giant pulmonary bulla and not prepared for surgical treatment; Perforation of the tympanic membrane; After closed drainage of pneumothorax or empyema; Uncontrolled hypertension (systolic blood pressure>200 mmHg, diastolic blood pressure>100 mmHg); Heart rate>120 times/minute; 2. Patients who cannot complete the questionnaire evaluation (including those who cannot read, express their opinions through alternative means, and understand the questions in the questionnaire, etc.); 3. Has been diagnosed as an aortic aneurysm; 4. Pregnant women; 5. Conforms to the contraindications of specific immunotherapy in the 2012 Chinese clinical practice expert consensus.

Design outcomes

Primary

MeasureTime frame
Asthma symptoms;Rhinitis symptoms;

Countries

China

Contacts

Public ContactQianli Ma

Chongqing Northern Kuanren Hospital

cqmql@163.com+86 13996030312

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026